AJR Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, S. W.
Right arrow Articles by Soto, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, S. W.
Right arrow Articles by Soto, J. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.05.0459
AJR 2006; 187:174-180
© American Roentgen Ray Society


Clinical Observations

Accuracy of MDCT in the Diagnosis of Choledocholithiasis

Stephan W. Anderson1, Brian C. Lucey1, Jose C. Varghese1 and Jorge A. Soto1

1 All authors: Radiology Department, Boston Medical Center, 88 East Newton Street, 2nd Floor, Boston, MA 02215.

Received March 15, 2005; accepted after revision July 10, 2005.

 
Address correspondence to S. W. Anderson (Stephan.Anderson{at}bmc.org).


Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
OBJECTIVE. Our purpose was to evaluate the diagnostic performance of contrast-enhanced and unenhanced MDCT, performed for various indications, in detecting choledocholithiasis.

CONCLUSION. Unenhanced and contrast-enhanced MDCT images, interpreted in PACS workstations with axial images, are moderately sensitive and specific for showing choledocholithiasis.

Keywords: biliary system • CT imaging • gastrointestinal radiology


Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Choledocholithiasis is a common complication of cholelithiasis. The reported incidence of common bile duct stones in patients undergoing cholecystectomy varies between 4% and 7% but may be as high as 33% in high-risk groups, such as elderly patients over 80 years of age [1]. Common bile duct stones are far more difficult to detect and result in greater morbidity and mortality than stones within the gallbladder. Multiple imaging tests have been used to diagnose stones in the common bile duct. In patients with suspected biliary tract disease and jaundice, sonography is typically the initial imaging technique used [2-4]. The reported sensitivity of sonography for detecting choledocholithiasis varies between approximately 20% [3] and 80% [4]. Traditionally, ERCP was the gold standard for investigation for bile duct diseases, but its role is now limited to therapeutic use [5]. Because of their improved safety profile, MR cholangiography [6, 7] and endoscopic sonography [8] have replaced ERCP for the diagnosis of bile duct stones.

Although CT is not the imaging technique of choice for patients with clinical suspicion of choledocholithiasis, it is commonly used in patients with jaundice, abnormal liver function test results, or other symptoms possibly related to the biliary tract. Previous studies have reported the performance of CT using different techniques for showing common bile duct stones. These include incremental [9] and helical CT [10-13] acquired both with [11] and without the addition of an IV contrast agent [12, 13]. Reported sensitivities have ranged from 20% [14] to as high as 88% [12].

In the emergency setting, CT scans are being acquired with increasing frequency in patients presenting with pain or other nonspecific abdominal complaints. Thus, CT often provides the first opportunity to detect bile duct stones in patients undergoing imaging for various medical conditions. Not surprisingly, CT scans with different protocols are acquired in many patients with common bile duct stones. With an almost universal use of MDCT in emergency radiology departments, acquisition of images with high spatial resolution is now routine. Thus, it is important to recognize the variable appearance of bile duct stones on CT images acquired with MDCT technology. In this study, we assessed the ability of MDCT performed with and without an IV contrast agent to detect common bile duct stones.


Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Subjects
Approval from our institutional review board was obtained for this retrospective study. The study population included all patients who underwent abdominal MDCT and ERCP within 3 months during a 3-year period (May 2001 to June 2004). Mean time between CT and ERCP was 7 days (range, same day to 15 days). This resulted in a study population of 72 patients consisting of 27 males and 45 females with a mean age of 54 years (range, 16-91 years). Thirty-three patients had studies performed with IV contrast agent only, 15 patients had scans performed without IV contrast agent only, and 24 patients had studies with and without an IV contrast agent. Thus, a total of 96 CT examinations were acquired in these 72 patients: 57 with IV contrast material (group 1) and 39 without IV contrast material (group 2). Indications for CT in the patient population were pancreatitis (n = 26), nonspecific abdominal pain (n = 22), trauma (n = 5), jaundice (n = 5), suspected pancreatic tumor (n = 2), biliary dilatation (n = 3), isolated abnormal liver function test results (n = 2), and others (n = 7). Indications for ERCP in the patient population were as follows: suspected choledocholithiasis from findings on other imaging techniques including sonography, CT, and MR cholangiopancreatography (MRCP) (n = 18); very high clinical suspicion of choledocholithiasis (n = 24); palliation/diagnosis of known or suspected neoplasm including pancreatic, gallbladder, and ampullary tumors (n = 17); trauma with suspected bile leak (n = 10); and treatment of pancreatic pseudocyst (n = 3).


Figure 1
View larger version (125K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1 82-year-old woman with periumbilical pain and weight loss. Axial contrast-enhanced CT image reveals common bile duct to be well visualized without evidence of choledocholithiasis (arrows). Even in retrospect, small stone retrieved at ERCP could not be identified.

 


Figure 2
View larger version (121K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2 47-year-old woman postcholecystectomy with persistent right upper quadrant pain. Axial CT image reveals small calcified common bile duct stone (arrow). At ERCP, several small stones of varying sizes were retrieved from common bile duct.

 


Figure 3
View larger version (123K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3 83-year-old woman with nonspecific abdominal pain. Transverse contrast-enhanced CT image reveals large soft-tissue attenuating common bile duct (CBD) stone (black arrow). Layering sludge is also noted in gallbladder (white arrow). At ERCP, 9-mm stone was retrieved from distal CBD.

 
CT Technique
All CT studies were performed on a 4-MDCT (MX 8000, Philips Medical Systems) scanner. Scans were acquired in a craniocaudal direction with the following parameters: slice thickness, 3.2 mm; reconstruction interval, 3 mm; pitch factor, 6; tube current, 120 kVp and 200-300 mAs. For those patients who received IV contrast material enhancement, 100 mL of iohexol (Optiray, 320 mg/mL; Mallinckrodt Imaging) was power injected through a cannula located in an antecubital or hand vein at a rate of 3-4 mL/s. The delay between the beginning of contrast material injection and image acquisition was 40 seconds for patients in whom the indication for the CT examination was suspected pancreatic disease and 60 seconds for all other indications. Eighty-five studies (89%) were performed with an oral contrast agent (900 mL of 2.2% barium sulfate suspension [Medescan; Lafayette Pharmaceuticals]). Of the 57 scans obtained using IV contrast material, 50 (88%) included administration of oral contrast material. Of the 39 scans without IV contrast material, 35 (90%) included oral contrast material. The radiologist in charge of the abdominal CT scan service at the time of the study made the decision to administer oral contrast material, IV contrast material, or both.

Image Analysis
The CT scan data sets were transferred to PACS workstations for analysis (Aurora, software 6.5; Merge eFilm). CT images were interpreted independently by two radiologists, observer 1 and observer 2, who had 9 and 3 years of experience, respectively, in cross-sectional abdominal imaging. Observers were free to use the window settings they preferred, which included narrow settings if a common duct stone was not initially identified on soft-tissue window settings. The radiologists had the option to generate multiplanar reformations of the axial images using a postprocessing software package incorporated into the PACS workstations (Voxar 3D; Barco). The radiologists received no clinical information or results of earlier or subsequent imaging studies. However, they were aware of the aim of the study.

Each radiologist was shown the group 1 (unenhanced) CT images separately in a randomized order with all patient details removed for analysis. After this, the observers were shown the group 2 (IV contrast-enhanced) CT images independently with the patient details removed for analysis. A diagnosis of choledocholithiasis was made when there was direct visualization of a stone as a high-attenuation focus or filling defect with surrounding bile (target sign, crescent sign) seen within the bile duct. Common bile duct caliber was not measured, and bile duct features such as dilatation, sharp amputation, or both were not used as ancillary signs of choledocholithiasis. When stones were identified, an analysis of the CT attenuation characteristics was made to classify them as diffusely calcified, partially calcified, or of soft-tissue attenuation.

All ERCP images were also interpreted on the PACS workstation by a gastrointestinal radiologist with more than 8 years of experience in cross-sectional abdominal imaging. Studies were classified as positive or negative for the presence of stones in the biliary tract. Stones in the gallbladder or cystic duct were not assessed in this study. If stones were found, the number of stones (up to a maximum of 10) was recorded, and the size of the largest stone was measured using electronic calipers on the workstation. The size of a stone was determined by its size relative to that of the endoscope taken to measure 11 mm. The results from the ERCP were used as the gold standard in determining the accuracy of CT findings.

Finally, after the results of the ERCP were disclosed to the radiologists, they were asked to perform a consensus review of the CT data sets to determine a possible explanation for any false-positive or false-negative interpretations made.

The originally dictated reports by the attending radiologists interpreting the CT scans at the time of completion of the studies were also evaluated. It was noted, based on the dictated reports, whether common bile duct stones were directly visualized or not at that time. A total of eight attending radiologists with variable experience (2-25 years of experience) were responsible for the original dictations.

Statistical Analysis
The independent interpretations by the two radiologists were used to determine the following diagnostic performance parameters for MDCT images: sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy. We calculated the 95% confidence intervals (CIs) for each of these parameters. This analysis was done separately for studies performed with IV contrast material and for the studies performed without IV contrast material. Finally, we evaluated the agreement between the two observers using the kappa statistics. Agreement was classified as follows: 0.00-0.20, poor; 0.21-0.40, fair; 0.41-0.60, moderate; 0.61-0.80, good; 0.81-1.00, very good.

Diagnostic performance parameters were also calculated for the original interpretations of the CT scans at the time of their completion. Sensitivity, specificity, PPV and NPV, and diagnostic accuracy were calculated including 95% CIs. Again, this was done separately for those studies performed with IV contrast material and those performed without IV contrast material.


Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
At ERCP, stones were found in 21 (29.2%) of the 72 patients. The stones ranged in number from one to more than 10, with 16 (76.2%) of the 21 patients having only a single stone in their bile duct. The stones ranged in maximum size from 2.5 to 28 mm, with a mean of 8.8 mm. Using CT evaluation, a stone was detected by at least one of the observers in 20 (95.2%) of the 21 patients with choledocholithiasis. Both reviewers failed to identify an ERCP-confirmed 3-mm calculus in one patient who had a dual CT examination performed (Fig. 1). In the 20 patients with choledocholithiasis identified at CT, the stones were classified as diffusely calcified in three (15%) (Fig. 2), as partially calcified in nine (45%), and of soft-tissue density in eight (40%) (Fig. 3).

Unenhanced CT (Group 1)
Thirteen (33%) of 39 patients who had unenhanced CT had choledocholithiasis at ERCP. Table 1 gives the results for the diagnosis of choledocholithiasis per CT study for the two observers. Between the two observers, a total of seven false-negative interpretations were made in six patients. In one of these patients who had a dual study, both observers missed a stone, a solitary 8-mm soft-tissue density stone situated within the distal common bile duct. Even on retrospective review, this stone was not apparent on the unenhanced CT, but both observers detected it prospectively on the IV contrast-enhanced study (Figs. 4A and 4B). On consensus review, the observers considered the stone impossible to detect because of its isodensity with surrounding soft tissue and the lack of a target or crescent sign. The remaining five studies were misinterpreted by only one of any of the two observers. At CT, the stones were classified as soft-tissue attenuation in two, as homogeneously calcified in two, and as having partial calcification (calcified rim) in one. On retrospective review, the consensus of the two observers was that all these stones were visible, but the major causes for not detecting them were related to their small size, similar density to surrounding tissue, confusion of dense lower bile duct stone for oral contrast material in the duodenum, or all three (Fig. 5).


View this table:
[in this window]
[in a new window]

 
TABLE 1: Results of Unenhanced CT (Group I) for Both Observers

 

Figure 4
View larger version (122K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4A 74-year-old woman with abdominal pain. Axial unenhanced CT image from study in which there was no evidence of choledocholithiasis.

 

Figure 5
View larger version (128K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4B 74-year-old woman with abdominal pain. Axial contrast-enhanced CT image reveals soft-tissue attenuating common bile duct (CBD) stone (black arrow). Also noted are dependently layering gallstones (white arrow). ERCP revealed 8-mm distal CBD stone.

 

Figure 6
View larger version (134K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5 72-year-old man presenting with diarrhea. Axial unenhanced CT image reveals large calcified focus within common bile duct (CBD) (arrow). This is false-negative for one observer that was misinterpretation of large CBD stone as oral contrast material within duodenal diverticulum. At ERCP, single large CBD stone was retrieved.

 

Between the two observers, a total of four false-positive interpretations were made in three patients using unenhanced CT for detection of choledocholithiasis. Interpretations of both observers were falsely positive in one patient with a dual study. In this same patient, both observers also falsely identified a common bile duct stone on the corresponding IV contrast-enhanced study. In the remaining two patients, false-positive misinterpretations were made by only one of any of the two observers. On consensus review, all these misinterpretations were thought to result from volume averaging from surrounding soft tissue such as the pancreas or common bile duct wall.

Contrast-Enhanced CT (Group 2)
Fifteen (26.3%) of 57 patients in this group were found to have bile duct stones at ERCP. Table 2 gives the results for the diagnosis of stones per CT study for the two observers. Between the two observers, a total of four false-negative interpretations were made in three patients. Of these, both observers made a false-negative interpretation in one patient. This was a patient with a 4.5-mm stone removed at ERCP that was not apparent by CT even on retrospective review. The remaining two false-negative interpretations occurred in two different patients, and on retrospective review, both observers agreed the stones were present: one as a minimally hyperattenuating stone and the other as a soft-tissue attenuation focus. At ERCP, a single 4-mm common bile duct stone was found in the first patient, and two stones measuring 3.5 mm and 6 mm were found in the second patient, respectively. The reasons for these misses were thought to be related to their small size and isodensity with surrounding tissue.


View this table:
[in this window]
[in a new window]

 
TABLE 2: Results of Contrast-Enhanced CT (Group 2) for Both Observers

 

The observers made a total of 12 false-positive interpretations in 10 patients using IV contrast-enhanced CT for detection of choledocholithiasis. Both observers made false-positive interpretations in two patients. Even at retrospective review, a calcified focus was thought to be clearly present within the common bile duct in both patients by both observers (Fig. 6). At ERCP performed between 1 and 6 days after the CT, no stones were found. On consensus review, the only explanation offered was that the stones likely passed while awaiting therapeutic ERCP. Of the remaining eight patients with false-positive CT studies, four were described as being of soft-tissue density; three were described as being partially calcified; and, in one patient, as being uniformly calcified. At consensus review, these false-positive findings were thought to have likely resulted from partial volume averaging from enhancing the wall of the common bile duct, interference from oral contrast material administered, and partial volume averaging from IV contrast-enhanced blood vessels coursing close to the bile duct (Fig. 7).


Figure 7
View larger version (128K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6 77-year-old woman with nonspecific abdominal pain. Axial unenhanced CT image clearly shows calcified focus within common bile duct (arrow). Radiologists hypothesized stone may have passed in interim between CT and ERCP, when no stone was found.

 

Figure 8
View larger version (146K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7 74-year-old man presenting with pain and pancreatic mass on sonogram. Axial contrast-enhanced CT image shows questionable hyperdense focus (arrow) within common bile duct (CBD). This is a false-positive for one observer, and at consensus review, hyperdensity was concluded to be partial volume averaging of enhanced blood vessel in immediate vicinity of CBD.

 
Statistical Analysis
Table 3 gives the sensitivity, specificity, PPV, NPV, and diagnostic accuracy for the detection of choledocholithiasis using unenhanced and IV contrast-enhanced CT for both observers. Overall, the sensitivity for diagnosis of choledocholithiasis between the two observers ranged from 69% to 87%, specificity from 83% to 92%, and accuracy from 84% to 88%. The kappa values for the interobserver agreement were 0.61 (good) for the unenhanced studies and 0.56 (moderate) for the contrast-enhanced studies.


View this table:
[in this window]
[in a new window]

 
TABLE 3: Performance Results for the Two Observers in the Analysis of Group 1 and Group 2 CT Examinations

 

Table 4 gives the sensitivity, specificity, PPV, NPV, and diagnostic accuracy for the detection of choledocholithiasis using the original interpretations at the time of the CT scans. Overall, the sensitivity is much decreased for both IV contrast-enhanced and unenhanced studies compared with the results described earlier by the two observers during this study. Specificity, however, is somewhat increased, with 100% and 98% for the unenhanced and IV contrast-enhanced groups, respectively.


View this table:
[in this window]
[in a new window]

 
TABLE 4: Performance Results Based on Original Interpretations at the Time of CT Scan

 


Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Although CT is not the primary technique for diagnosis of choledocholithiasis, bile duct stones are often found in patients undergoing abdominal CT for various indications in routine clinical practice. CT is being increasingly used in patients presenting to the emergency department with abdominal pain, nausea, vomiting, or other nonspecific abdominal symptoms. Thus, it is important for the practicing radiologist to recognize the variable appearance of bile duct stones on CT and to be aware of the limitations of diagnosis. The published sensitivities for detection of choledocholithiasis range from 20% to 90% [2, 3, 10, 12-16], with a mean sensitivity of approximately 80%.

The ability to detect bile duct stones at CT depends on a number of factors related to the stone (size, shape, position, density), bile duct (dilated vs nondilated), technology used (conventional vs helical CT), technique used (slice thickness, reconstruction interval, pitch, kVp, administration of contrast material), patient selection (screening population vs all comers), and interpreter variability (experience, anticipation of bile duct stones). The detection of nearly isoattenuating stones may be improved by narrow window settings, a technique that has been used in previous studies [12]. As noted, our radiologists used narrow settings if a common duct stone was not identified on standard soft-tissue window settings. It is well recognized that small stones situated within the intrahepatic ducts or impacted at the ampulla are difficult to identify, particularly in nondilated biliary ducts.

The attenuation of bile duct stones strongly influences the ability to detect them using CT. Heavily calcified stones are relatively easily identified, whereas soft-tissue density stones can be isoattenuating to surrounding tissue, making them difficult to identify. The attenuation of biliary stones varies with their composition. They can be made up of varying amounts of bile pigment, cholesterol, fatty acids, and calcium. Pure cholesterol stones are iso- or slightly hypoattenuating relative to bile, making them difficult, if not impossible, to detect. This imposes a theoretic upper limit for the CT detectability of choledocholithiasis of approximately 80% that cannot be improved on irrespective of any future advances in CT technology [17-19].

Even in light of the fact that Jeffrey et al. [16] achieved a sensitivity of 90% in diagnosing choledocholithiasis using conventional (incremental) CT, it is generally accepted that helical CT is superior in the diagnosis of choledocholithiasis. The potential for helical CT, especially using MDCT technology, to image the anatomy using thin slices in a single breath-hold and to reconstruct those slices retrospectively using variable overlap should reduce much of the image degradation previously experienced from motion artifacts and volume averaging. For our study, we used 4-MDCT and acquired images with 3.2-mm thickness through the entire abdomen and pelvis in a single breath-hold (averaging 12 seconds) with retrospective image reconstruction at 3-mm intervals. Our accuracy of 84-88% obtained using our technique may have suffered compared with that of other investigators who performed CT using thinner slices focused around the biliary tract only.

We also performed our CT examinations using various protocols for oral and IV contrast administration. Patients such as those with right flank pain and suspected renal stones had CT performed without any contrast material administration, patients such as those with suspected bowel disease had administration of both oral and IV contrast material, and patients being evaluated after major trauma had IV contrast material administration only. It is generally believed that administration of oral contrast material, IV contrast material, or both reduces the accuracy for diagnosis of choledocholithiasis. In our study, we encountered false-positive findings for stones resulting from reflux of oral contrast material into the lower bile duct and from partial volume averaging from IV contrast-enhanced bile duct mucosa. However, we also found at least one instance where administration of IV contrast material helped; this was in a patient with a soft-tissue density stone situated at the ampulla was only made obvious after IV contrast enhancement of the surrounding bile duct wall. In clinical practice, both oral and IV contrast material are frequently used because they make the biliary anatomy clearer and they help with diagnoses of mass lesions such as neoplasms. At least from our limited data, it appears that the administration of IV contrast material does not limit the accuracy of MDCT for diagnosis of choledocholithiasis in patients undergoing routine abdominal imaging.

In our study, we achieved a sensitivity of 69-87%, specificity of 83-92%, and accuracy of 84-88% in the CT diagnosis of choledocholithiasis. Twenty of the 21 patients with stones were identified by at least one of the two observers, and stones in only one patient were missed by both observers. The stones missed were mostly of soft-tissue or partially calcified density, measuring less than 6 mm, and situated in the lower common bile duct. The effect of bile duct size on sensitivity was not evaluated in this study. On retrospective review, the major reasons for missing stones were thought to be related to their small size, similar density to surrounding tissue, confusion of dense lower bile duct stones for oral contrast material in the duodenum, or all three. False-positive results occurred in our study related to partial volume averaging from surrounding tissues including opacified blood vessels coursing close to the bile duct, IV contrast enhancement of bile duct mucosa, and reflux of oral contrast material into the lower common bile duct. It is also highly likely that a few of our false-positive results were related to real bile duct stones that had passed by the time ERCP was performed. As CT technology continues to improve with the increasing use of 16-, 32-, and 64-MDCT, it is likely that the accuracy for detection of choledocholithiasis in patients undergoing routine abdominal CT will improve compared with our results. The increasing resolution that will be afforded and decreasing acquisition time limiting motion artifacts may eliminate some of the false-positive and negative interpretations described in our study. However, for the theoretic limitations just mentioned, it cannot be expected to rival the excellent results obtained with MR cholangiography or endoscopic sonography.

Because of its retrospective nature, our study has a number of limitations. First, the mean delay of 7 days for ERCP after CT probably led to passage of some stones, resulting in an increased false-positive rate at CT. Second, the fact that the observers in this study were primed for detection of choledocholithiasis likely led to an improved sensitivity for detection for bile duct stones compared with real-time interpretations at the time of the examination. This likely explains the large disparity between sensitivities achieved by the two observers in this study compared with that achieved at the original interpretations at the time of the CT scans. The fact that the radiologists involved in this study were primed for the detection of common bile duct stones likely also resulted in overdiagnosing choledocholithiasis, which explains the disparity between specificity achieved in this study and that achieved at the time of the original interpretation.

In conclusion, unenhanced and contrastenhanced CT performed with a 4-MDCT scanner is moderately accurate in the diagnosis of choledocholithiasis in patients undergoing imaging for various indications. The impact of further improvements in CT technology, such as acquisition of images with isotropic voxels, should be investigated.


References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. DenBesten L, Doty JE. Pathogenesis and management of choledocholithiasis. Surg Clin North Am1981; 61:893 -907[Medline]
  2. Baron RL, Stanley RJ, Lee JK, et al. A prospective comparison of the evaluation of biliary obstruction using computed tomography and ultrasonography. Radiology 1982;145 : 91-98[Abstract/Free Full Text]
  3. Mitchell S, Clark R. A comparison of computed tomography and sonography in choledocholithiasis. AJR1984; 142:729 -733[Abstract/Free Full Text]
  4. Wermke W, Schulz HJ. Sonographic diagnosis of bile duct calculi: results of a prospective study of 222 cases of choledocholithiasis [in German]. Ultraschall Med 1987;8 : 116-120[Medline]
  5. NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy. NIH Consens State Sci Statement 2002;19 : 1-26
  6. Soto JA, Alvarez O, Munera F, Velez SM, Valencia J, Ramirez N. Diagnosing bile duct stones: comparison of unenhanced helical CT, oral contrast-enhanced CT cholangiography and MR cholangiography. AJR 2000; 175:1127 -1134[Abstract/Free Full Text]
  7. Griffin N, Wastle ML, Dunn WK, Ryder SD, Beckingham IJ. Magnetic resonance cholangiopancreatography versus endoscopic retrograde cholangiopancreatography in the diagnosis of choledocholithiasis. Eur J Gastroenterol Hepatol 2003;15 : 809-813[CrossRef][Medline]
  8. Canto MI, Chak A, Stellato T, Sivak MV Jr. Endoscopic ultrasonography versus cholangiography for the diagnosis of choledocholithiasis. Gastrointest Endosc1998; 47:439 -448[CrossRef][Medline]
  9. Baron RL. Common bile duct stones: reassessment of criteria for CT diagnosis. Radiology 1987;162 : 419-424[Abstract/Free Full Text]
  10. Soto JA, Velez SM, Guzman J. Choledocholithiasis: diagnosis with oral contrast enhanced CT cholangiography. AJR1997; 172:943 -948
  11. Miller FH, Hwang CM, Gabriel H, Goodhartz LA, Omar AJ, Parsons WG III. Contrast-enhanced helical CT of choledocholithiasis. AJR 2003; 181:125 -130[Free Full Text]
  12. Neitlich J, Topazian M, Smith RC, Gupta A, Burrell MI, Rosenfield AT. Detection of choledocholithiasis: comparison of unenhanced helical CT and endoscopic retrograde cholangiopancreatography. Radiology 1997;203 : 753-757[Abstract/Free Full Text]
  13. Jimenez CI, delOlmo LM, Perez HM. Helical CT without contrast in choledocholithiasis. Eur Radiol 2001;11 : 197-201[CrossRef][Medline]
  14. Pasanen P, Partanen K, Pikkarainen P, Alhava E, Pirinen A, Janatuinen E. Ultrasonography, CT and ERCP in the diagnosis of choledochal stones. Acta Radiol 1992;33 : 53-56[Medline]
  15. Sugiyama M, Atomi Y. Endoscopic ultrasonography for diagnosing choledocholithiasis: a prospective comparative study with ultrasonography and computed tomography. Gastrointest Endosc1997; 45:143 -146[CrossRef][Medline]
  16. Jeffrey RB, Federle MP, Laing FC, Wall S, Rego J, Moss AA. Computed tomography of choledocholithiasis. AJR1983; 140:1179 -1183[Abstract/Free Full Text]
  17. Baron RL, Rohrmann CA Jr, Lee SP, Shuman WP, Teefey SA. CT evaluation of gallstones in vitro: correlation with chemical analysis. AJR 1988; 151:1123 -1128[Abstract/Free Full Text]
  18. Brakel K, Lameris JS, Nijs HG, Terpstra OT, Steen G, Blijenberg BC. Predicting gallstone composition with CT: in vivo and in vitro analysis. Radiology 1990;174 : 337-341[Abstract/Free Full Text]
  19. Baron RL. Diagnosing choledocholithiasis: how far can we push helical CT? Radiology 1997;203 : 601-603[Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
S. W. Anderson, E. Rho, and J. A. Soto
Detection of Biliary Duct Narrowing and Choledocholithiasis: Accuracy of Portal Venous Phase Multidetector CT
Radiology, May 1, 2008; 247(2): 418 - 427.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, S. W.
Right arrow Articles by Soto, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, S. W.
Right arrow Articles by Soto, J. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS